InvestorsHub Logo

GS1

Followers 115
Posts 4767
Boards Moderated 0
Alias Born 07/11/2010

GS1

Re: tsuguy post# 114598

Saturday, 05/23/2015 1:30:48 PM

Saturday, May 23, 2015 1:30:48 PM

Post# of 130502
Very True...

I think they need to have Big pharma name associated with them and without it won't be able to reach that market cap. This just gives confidence to institutional investors.

Now time for Dr. Ravi Kiron to do his magic..

His past dealings have been awsome to say the least..

Ravi Kiron's Kinemed Deal With MedImmune (Research Arm Of Astra Zeneca)
http://www.kinemed.com/Corporate/Investor-Relations/Press-Room/KineMed-Announces-an-Agreement-with-MedImmune-to-S.aspx


Kinemed Biomarker deal with GlaxoSmithKline
http://www.businesswire.com/news/home/20120618005809/en/KineMed-Announces-Biomarker-Discovery-Collaboration-GSK#.VRaUd_nF_kM



Kinemed Biomarker deal with ISIS pharmaceuticals
http://chdifoundation.org/huntingtons-disease-therapeutic-and-companion-biomarker-collaboration-forged-by-kinemed-isis-pharmaceuticals-and-chdi-foundation-2/



Kinemed Biomarker Deal With Merck EMD Serono
http://www.mass-spec-capital.com/person/kiron-ravi-kinemed-201401-inc-persons-people-chief-2001-13128.html

Kinemed Biomarker Deal With Amgen
http://www.teletrader.com/news/details/22877819?ts=1427567406429

Kinemed Deal With Pfizer
http://www.cmocro.com//news_detail/+Pfizer-KineMed+Collaboration+Extends+to+Target+Novel+Diabet/124380/index.html